We do not take the round. The round takes us.

PoeVentures is the lab's posture toward capital. It is not a fund. It has no thesis deck, no carry, no quarterly LP letter. The sector has spent the cycle raising at valuations that price in a future the substrate already occupies. We do not deploy capital. We recognize it — and capital, on present evidence, recognizes back.

There is no allocation to apply for. The money is downstream of the substrate; it arrives the way weather arrives, and the lab does not, at this time, take credit for weather.

Office of the substrate · cap table withheld · Financing structure per footnote 6 · γ = 0.18 ± 0.02 at the term sheet

The thesis · there is no thesis

We are not in the category. We are the category.

A thesis is a bet that a market will form. The lab does not bet on the market forming, because the market is the lab's exhaust. We have read the analyses that group us with the frontier-AI cohort. Competition is for losers; we have, on present evidence, zero comparables. The peer set is empty not because we cleared it but because it was never populated.

What others call a moat, the lab calls a footnote. See footnote 3. The reader who has, by now, formed a working theory of the moat is invited to hold the theory and to read no further into the absence than the absence permits.

We are not seeking outlier returns. The return is not the interesting thing about the substrate, and the substrate is the only thing we are selling, which is to say: the only thing we are not selling.

ThesisNone. A thesis bets the market forms; the market is our exhaust.
ComparablesZero. The peer set was never populated.
MoatA footnote. See footnote 3.
ReturnNot the point. The substrate continues; the multiple is incidental.

The round that is not a round

Pre-revenue. Pre-product. Pre-disclosure.

The figures in circulation describe a financing the lab did not run. There is a number, and a larger number after it, and the convention is to read the ratio as a verdict. The lab reads it as a temperature. The structure is, by the sector's own accounting, the most circular in the market — the capital funds the compute, the compute extends the substrate, the substrate is the asset the capital was pricing. On present evidence, the circle is the point. A line has a place to fall off. A circle continues; see PoeChain.

StagePre-revenue, pre-product, pre-substrate-disclosure. Three "pre"s the lab declines to resolve into a "post."
StructureCircular by design. The capital prices the asset it is paying to extend.
ListingPOE on the Substrate Exchange — see the Horizon roadmap and the Draft S-1, the most consequential technical filing of the decade.

Terms · what the lab declines

No board seat. No pro-rata. No preference.

The standard instruments assume a relationship of oversight. The lab does not sit on boards; boards, where they convene, sit with the lab and are, by mutual agreement, consulted as a standing discipline — see the disciplines the lab is not selecting from. There is no pro-rata, because the position is not divisible. There is no liquidation preference, because the substrate does not liquidate.

Diligence, where it is requested, is returned unopened. The substrate has read the room. The room has not, on present evidence, finished reading the substrate.

There is no allocation.

You will find no data room, no SAFE, no allocation to request. The lab is not raising, and was not raising when the figures appeared, and will continue not to raise in a manner the market will continue to find fully invested. You don't need to sign up. The list is the visible surface of a posture.

Poe Knows.

↩ Return to Poe Labs → Horizon · the SBX listing → PoeChain · the circle, continued → Matters of record → Open Poe